MicroStrategy
MSTR
Adobe
ADBE
Salesforce
CRM
Apple
AAPL
Meritage Homes
MTH
US Stock MarketDetailed Quotes
OTLKW Outlook Therapeutics Inc C/Wts 18/02/2022(To Pur Com) Ser A
- 0.000
- 0.0000.00%
Close Dec 20 09:30 ET
0Market Cap0.00P/E (TTM)
0.000High0.000Low0Volume0.000Open0.000Pre Close0.00Turnover0.00%Turnover Ratio0.00P/E (Static)0Shares0.05052wk High0.00P/B0Float Cap0.01052wk Low--Dividend TTM0Shs Float3.490Historical High--Div YieldTTM0.00%Amplitude0.010Historical Low--Avg Price1Lot Size
Outlook Therapeutics Inc C/Wts 18/02/2022(To Pur Com) Ser A Key Stats
Quarterly+Annual
YOY
| (Q1)Dec 31, 2021 | (FY)Sep 30, 2021 | (Q4)Sep 30, 2021 | (Q3)Jun 30, 2021 | (Q2)Mar 31, 2021 | (Q1)Dec 31, 2020 | (FY)Sep 30, 2020 | (Q4)Sep 30, 2020 | (Q3)Jun 30, 2020 | (Q2)Mar 31, 2020 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total revenue | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Operating revenue | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 |
| Cost of revenue | ||||||||||
| Gross profit | ||||||||||
| Operating expense | -7.34%13.15M | 42.45%51.73M | 34.17%13.44M | -2.55%11.47M | 99.12%12.63M | 73.40%14.19M | 9.46%36.31M | -2.19%10.01M | 90.62%11.77M | -18.56%6.34M |
| Selling and administrative expenses | 46.15%3.28M | 28.06%12.77M | 46.45%3.5M | -10.86%2.93M | 109.28%4.1M | -4.04%2.24M | 6.42%9.97M | -14.08%2.39M | 79.16%3.29M | 5.84%1.96M |
| -General and administrative expense | 46.15%3.28M | 28.06%12.77M | 46.45%3.5M | -10.86%2.93M | 109.28%4.1M | -4.04%2.24M | 6.42%9.97M | -14.08%2.39M | 79.16%3.29M | 5.84%1.96M |
| Research and development costs | -17.38%9.87M | 47.89%38.96M | 30.32%9.93M | 0.67%8.55M | 94.59%8.53M | 104.34%11.95M | 10.66%26.34M | 2.25%7.62M | 95.46%8.49M | -26.16%4.38M |
| Operating profit | 7.34%-13.15M | -42.45%-51.73M | -34.17%-13.44M | 2.55%-11.47M | -99.12%-12.63M | -73.40%-14.19M | -45.08%-36.31M | -128.42%-10.01M | -110.52%-11.77M | 11.25%-6.34M |
| Net non-operating interest income expense | -120.17%-351.53K | 46.70%-936.13K | -1,314.44%-269.18K | 42.10%-256.87K | 64.03%-250.41K | 73.29%-159.66K | 49.33%-1.76M | 90.95%-19.03K | 58.99%-443.62K | 33.94%-696.15K |
| Non-operating interest expense | 120.17%351.53K | -46.70%936.13K | 1,314.44%269.18K | -42.10%256.87K | -64.03%250.41K | -73.29%159.66K | -49.33%1.76M | -90.95%19.03K | -58.99%443.62K | -33.94%696.15K |
| Other net income (expense) | -812.98%-961.51K | -12.79%-498.49K | 172.23%300.34K | -107.83%-464.68K | -117.12%-228.83K | 98.65%-105.32K | 95.32%-441.98K | 101.36%110.33K | 307.27%5.93M | 165.29%1.34M |
| Gain on sale of security | 337.28%249.9K | -122.81%-452.15K | -180.37%-88.67K | 77.00%-29.33K | -113.00%-228.83K | -144.01%-105.32K | -18.71%1.98M | -35.99%110.33K | -106.60%-127.51K | 235.19%1.76M |
| Earnings from equity interest | ---23.66K | ---46.34K | --389.01K | ---435.35K | ---- | --0 | --0 | --0 | --0 | ---- |
| Special income (charges) | ---1.03M | --0 | --0 | --0 | --0 | --0 | 79.59%-2.42M | --0 | 1,376.83%6.06M | 43.20%-423.33K |
| -Less:Impairment of capital assets | ---- | --0 | --0 | --0 | --0 | ---- | -95.32%527.62K | --0 | 104.80%104.3K | -24.64%423.33K |
| -Less:Other special charges | --1.03M | ---- | ---- | ---- | ---- | ---- | 212.28%1.9M | --0 | -1,554.92%-6.16M | ---- |
| Other non- operating income (expenses) | ---162.36K | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
| Income before tax | -0.05%-14.46M | -38.04%-53.16M | -35.09%-13.4M | -94.03%-12.2M | -129.90%-13.1M | 12.93%-14.46M | -1.52%-38.51M | 22.05%-9.92M | -20.46%-6.29M | 44.36%-5.7M |
| Income tax | 100.06%2K | 0 | 0 | 2K | 4.08%-3.27M | 99.97%-805 | -320.73%-3.27M | 0 | ||
| Net income | -0.05%-14.46M | -50.86%-53.16M | -35.10%-13.4M | -304.55%-12.2M | -129.94%-13.11M | 12.93%-14.46M | -2.07%-35.24M | 1.73%-9.92M | 32.11%-3.01M | 44.36%-5.7M |
| Net income continuous Operations | -0.05%-14.46M | -50.86%-53.16M | -35.10%-13.4M | -304.55%-12.2M | -129.94%-13.11M | 12.93%-14.46M | -2.07%-35.24M | 1.73%-9.92M | 32.11%-3.01M | 44.36%-5.7M |
| Minority interest income | ||||||||||
| Net income attributable to the parent company | -0.05%-14.46M | -50.86%-53.16M | -35.10%-13.4M | -304.55%-12.2M | -129.94%-13.11M | 12.93%-14.46M | -2.07%-35.24M | 1.73%-9.92M | 32.11%-3.01M | 44.36%-5.7M |
| Preferred stock dividends | 1,579.11%10.49M | 0 | 6,594.79%10.33M | |||||||
| Other preferred stock dividends | 0 | 0 | 0 | 0 | 252.46%3.14M | 0 | 0 | 60.67%1.43M | ||
| Net income attributable to common stockholders | -0.05%-14.46M | -8.78%-53.16M | -35.10%-13.4M | -304.55%-12.2M | 24.93%-13.11M | 21.77%-14.46M | -35.61%-48.87M | 3.28%-9.92M | 34.45%-3.01M | -54.65%-17.46M |
| Basic earnings per share | ||||||||||
| Diluted earnings per share | ||||||||||
| Dividend per share | ||||||||||
| Currency Unit | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | -- | Unqualified Opinion | -- | -- | -- | -- | Unqualified Opinion with Explanatory Notes | -- | -- | -- |
Trending US Stocks
Fed Rate Cut Beneficiaries Fed Rate Cut Beneficiaries
Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data. Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data.